Chang-Jen Jiang - 02 Aug 2021 Form 3 Insider Report for ABVC BIOPHARMA, INC. (ABVC)

Role
Director
Signature
/s/ Chang-Jen Jiang
Issuer symbol
ABVC
Transactions as of
02 Aug 2021
Net transactions value
$0
Form type
3
Filing time
15 Nov 2021, 11:24:30 UTC
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ABVC Common Stock 5,949 02 Aug 2021 See Footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Dr. Chang-Jen Jiang holds 1,343 shares of common stock in the Company through his ownership in BioFirst, 6 shares of the Company's common stock through Rgene, and the rest of 4,600 shares through direct ownership.